Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.
Hershkovitz O, Jarahian M, Zilka A, Bar-Ilan A, Landau G, Jivov S, Tekoah Y, Glicklis R, Gallagher JT, Hoffmann SC, Zer H, Mandelboim O, Watzl C, Momburg F, Porgador A. Hershkovitz O, et al. Among authors: jarahian m. Glycobiology. 2008 Jan;18(1):28-41. doi: 10.1093/glycob/cwm125. Epub 2007 Nov 15. Glycobiology. 2008. PMID: 18006589
Expression and Purification of a Bispecific Antibody against CD16 and Hemagglutinin Neuraminidase (HN) in E. Coli for Cancer Immunotherapy.
Bahrololoumi Shapourabadi M, Roohvand F, Arashkia A, Mohajel N, Abdoli S, Shahosseini Z, Momburg F, Jarahian M, Abolhassani M, Azadmanesh K. Bahrololoumi Shapourabadi M, et al. Among authors: jarahian m. Rep Biochem Mol Biol. 2020 Apr;9(1):50-57. doi: 10.29252/rbmb.9.1.50. Rep Biochem Mol Biol. 2020. PMID: 32821751 Free PMC article.
Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapy.
Bahrololoumi Shapourabadi M, Momburg F, Roohvand F, Jarahian M, Mohajel N, Arashkia A, Hajari Taheri F, Abbasalipour M, Azadmanesh K. Bahrololoumi Shapourabadi M, et al. Among authors: jarahian m. Int Immunopharmacol. 2021 Jul;96:107762. doi: 10.1016/j.intimp.2021.107762. Epub 2021 May 31. Int Immunopharmacol. 2021. PMID: 34162140
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
Marofi F, Rahman HS, Thangavelu L, Dorofeev A, Bayas-Morejón F, Shirafkan N, Shomali N, Chartrand MS, Jarahian M, Vahedi G, Mohammed RN, Shahrokh S, Akbari M, Khiavi FM. Marofi F, et al. Among authors: jarahian m. Stem Cell Res Ther. 2021 Mar 22;12(1):200. doi: 10.1186/s13287-021-02251-7. Stem Cell Res Ther. 2021. PMID: 33752707 Free PMC article. Review.
CAR-NK cell in cancer immunotherapy; A promising frontier.
Marofi F, Abdul-Rasheed OF, Rahman HS, Budi HS, Jalil AT, Yumashev AV, Hassanzadeh A, Yazdanifar M, Motavalli R, Chartrand MS, Ahmadi M, Cid-Arreguid A, Jarahian M. Marofi F, et al. Among authors: jarahian m. Cancer Sci. 2021 Sep;112(9):3427-3436. doi: 10.1111/cas.14993. Epub 2021 Jul 7. Cancer Sci. 2021. PMID: 34050690 Free PMC article. Review.
37 results